Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Multicentre Clinical Trial, Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) and Standard of Care Versus Standard of Care Alone in the Healing of Chronic Diabetic Foot Ulcers

NCT04457752 is registered in ClinicalTrials.gov with SerenaGroup, Inc. as lead sponsor.

NCT NCT04457752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Multicentre Clinical Trial, Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) and Standard of Care Versus Standard of Care Alone in the Healing of Chronic Diabetic Foot Ulcers
Lead sponsor
SerenaGroup, Inc.
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2020
Completion date
March 31, 2023
Enrollment
124 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chronic diabetic foot ulcers